For years, people laughed off the idea that cannabinoids might have real medical potential beyond pain relief and anxiety. Now the science keeps moving forward anyway.
A new scientific review found that CBD may hold promise as an anticancer agent in dogs, with researchers reviewing studies involving lymphoma, osteosarcoma, mammary cancer, glioma, and other canine cancers. The review concluded that CBD consistently showed antiproliferative and proapoptotic effects — meaning it may help slow cancer cell growth and trigger cancer cell death.
Importantly, the researchers also noted that CBD has generally been shown to be safe and well-tolerated in dogs, which is why veterinarians and pet owners have become increasingly interested in cannabinoid therapies.
That doesn’t mean CBD is a miracle cure. Most of the research is still preclinical, and scientists are clear that more studies and clinical trials are needed before definitive conclusions can be made. But the bigger point is this: cannabis research keeps uncovering therapeutic potential in places critics once dismissed outright.
First it was epilepsy.
Then chronic pain.
Then inflammation.
Now researchers are seriously studying cancer applications — not just in humans, but even in veterinary medicine.
The conversation around cannabis has changed dramatically over the last decade, and studies like this are a reminder that we’ve barely scratched the surface of what these compounds may actually do.
Dabbin-Dad Newsroom
